IP Verse

Intas Pharmaceuticals Ltd. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Intas Pharmaceuticals Ltd.

Patent Number:
EP2653162
Title:
Methods Of Administering Fluvoxamine Therapy
Applicant:
INTERMUNE, INC.
Opposition Date:
Feb 19, 2021
Patent Number:
EP2506850
Title:
Methods Of Administering Pirfenidone Therapy
Applicant:
INTERMUNE, INC.
Opposition Date:
Feb 15, 2021
Patent Number:
EP3246021
Title:
Apixaban Formulations
Applicant:
BRISTOL-MYERS SQUIBB HOLDINGS IRELAND
Opposition Date:
Aug 12, 2020
Patent Number:
EP3251660
Title:
Apixaban Formulations
Applicant:
BRISTOL-MYERS SQUIBB HOLDINGS IRELAND
Opposition Date:
Jul 15, 2020
Patent Number:
EP3257500
Title:
Apixaban Formulations
Applicant:
BRISTOL-MYERS SQUIBB HOLDINGS IRELAND
Opposition Date:
Jul 15, 2020
Patent Number:
EP3017811
Title:
Apixaban Formulations
Applicant:
BRISTOL-MYERS SQUIBB COMPANY
Opposition Date:
Sep 4, 2019
Patent Number:
EP3023095
Title:
Direct Compression Formulation And Process
Applicant:
NOVARTIS AG
Opposition Date:
Feb 15, 2019
Patent Number:
EP2956129
Title:
Pharmaceutical Compositions Containing Dexketoprofen And Tramadol
Applicant:
LABORATORIOS MENARINI S.A.
Opposition Date:
Jan 18, 2019
Patent Number:
EP2792369
Title:
Bendamustine Cyclopolysaccharide Compositions
Applicant:
SOFTKEMO PHARMA CORP.
Opposition Date:
Jan 17, 2019
Patent Number:
EP1983984
Title:
Tuberous Sclerosis Treatment
Applicant:
NOVARTIS AG
Opposition Date:
Dec 5, 2018

Latest patents of Intas Pharmaceuticals Ltd. opposed by its competitors

Patent:
EP3833335
Grant Date:
Aug 31, 2022
Title:
Pharmaceutical Composition Comprising Hmg-Coa Reductase Inhibitors And Fenofibrate
Oppositions:
2
Patent:
EP2978426
Grant Date:
Nov 13, 2019
Title:
Stable Tigecycline Composition
Oppositions:
1

Competitors of Intas Pharmaceuticals Ltd.

BRISTOL-MYERS SQUIBB HOLDINGS IRELAND

BRISTOL-MYERS SQUIBB HOLDINGS IRELAND UNLIMITED COMPANY

PFIZER INC.

Want to track Intas Pharmaceuticals Ltd.?

Feel free to send us a message here and we will get back to you